March 07, 2018

Bayer in exclusive talks with BASF on the sale of vegetable seeds business

Leverkusen, March 7, 2018 - Bayer is in exclusive talks with BASF on the sale
of its entire vegetable seeds business. Through this and related moves, Bayer
is confident of fully addressing all concerns of the European Commission.

On October 13, 2017, Bayer had already agreed to sell selected Crop Science
businesses to BASF for 5.9 billion euros. This first package covers Bayer's
global glufosinate-ammonium business and the related LibertyLink™ technology
for herbicide tolerance, essentially all of the company's field crop seed
businesses, and the respective research and development capabilities. The seed
businesses being divested include the global cotton seed business (excluding
India and South Africa), the oilseed rape/canola business in North America and
Europe, and the soybean seed business.

Any sales and licenses would be subject to a successful closing of the proposed
acquisition of Monsanto, which remains subject to customary closing conditions,
including receipt of required regulatory approvals. The European Commission
recently extended the examination deadline for the acquisition until April 5.
Bayer is working closely with the authorities worldwide in order to
successfully close the transaction in the second quarter of 2018.

About Bayer

Bayer is a global enterprise with core competencies in the Life Science fields
of health care and agriculture. Its products and services are designed to
benefit people and improve their quality of life. At the same time, the Group
aims to create value through innovation, growth and high earning power. Bayer
is committed to the principles of sustainable development and to its social and
ethical responsibilities as a corporate citizen. In fiscal 2017, the Group
employed around 99,800 people and had sales of EUR 35.0 billion. Capital
expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For
more information, go to

Cautionary Statements Regarding Forward-Looking Information
Certain statements contained in this communication may constitute "forward-
looking statements." Actual results could differ materially from those
projected or forecast in the
Forward-looking statements
. The factors that could
cause actual results to differ materially include the following: uncertainties
as to the timing of the transaction; the possibility that the parties may be
unable to achieve expected synergies and operating efficiencies in the merger
within the expected time-frames or at all and to successfully integrate
Monsanto's operations into those of Bayer; such integration may be more
difficult, time-consuming or costly than expected; revenues following the
transaction may be lower than expected; operating costs, customer loss and
business disruption (including, without limitation, difficulties in maintaining
relationships with employees, customers, clients or suppliers) may be greater
than expected following the announcement of the transaction; the retention of
certain key employees at Monsanto; risks associated with the disruption of
management's attention from ongoing business operations due to the transaction;
the conditions to the completion of the transaction may not be satisfied, or
the regulatory approvals required for the transaction may not be obtained on
the terms expected or on the anticipated schedule; the parties' ability to meet
expectations regarding the timing, completion and accounting and tax treatments
of the merger; the impact of the refinancing of the loans taken out for the
transaction, the impact of indebtedness incurred by Bayer in connection with
the transaction and the potential impact on the rating of indebtedness of
Bayer; the effects of the business combination of Bayer and Monsanto, including
the combined company's future financial condition, operating results, strategy
and plans; other factors detailed in Monsanto's Annual Report on Form 10-K
filed with the SEC for the fiscal year ended August 31, 2017 and Monsanto's
other filings with the SEC, which are available at and on
Monsanto's website at; and other factors discussed in Bayer's
public reports which are available on the Bayer website at Bayer
and Monsanto assume no obligation to update the information in this
communication, except as otherwise required by law. Readers are cautioned not
to place undue reliance on these forward-looking statements that speak only as
of the date.